Historical salary details - Ms. Elizabeth G. O’Farrell, Chairman of the Board and Lead Independent Directo, Geron Corp.
Ms. Elizabeth G. O’Farrell is the Chairman of the Board and Lead Independent Directo of Geron Corp..
Ms. Elizabeth G. O’Farrell
Chairman of the Board and Lead Independent Directo
-
Gross Remuneration
-
Current Company
Geron Corp.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Geron Corp. | Chairman of the Board and Lead Independent Directo | - | - |
| 2024 | Genmab - ADR | Independent Director | 2.6 M | 36.8 % |
| 2024 | LENSAR Inc | Independent Director | - | - |
| 2024 | Geron Corp. | Lead Independent Director | - | - |
| 2023 | Genmab - ADR | Independent Director | 1.9 M | - |
| 2023 | Geron Corp. | Independent Director | - | - |
| 2022 | Geron Corp. | Independent Director | 191.1 K | 47.3 % |
| 2022 | LENSAR Inc | Independent Director | 95.0 K | -72.3 % |
| 2022 | Inhibikase Therapeutics Inc | Independent Director | 43.3 K | -58.7 % |
| 2022 | Inhibikase Therapeutics Inc | Independent Director | - | - |
| 2022 | Genmab - ADR | Independent Director | - | - |
| 2021 | LENSAR Inc | Independent Director | 343.1 K | - |
| 2021 | Geron Corp. | Independent Director | 129.8 K | -5.1 % |
| 2021 | Inhibikase Therapeutics Inc | Independent Director | 105 K | 166.7 % |
| 2020 | Geron Corp. | Independent Director | 136.7 K | -47.0 % |
| 2020 | Inhibikase Therapeutics Inc | Independent Director | 39.4 K | -89.9 % |
| 2020 | LENSAR Inc | Independent Director | - | - |
| 2019 | Inhibikase Therapeutics Inc | Independent Director | 389.8 K | - |
| 2019 | Geron Corp. | Independent Director | 258.2 K | - |
| 2019 | LENSAR Inc | Chairman of the Board | - | - |
| 2018 | Geron Corp. | Independent Director | - | - |